The Impact of INA and SRF’s Investment in Kimia Farma
The capital injection by the Indonesia Investment Authority and Silk Road Fund to PT Kimia Farma Tbk and PT Kimia Farma Apotek) opened opportunities for the company's expansion into international markets. Associate Director of Research and Investment Pilarmas Investindo Sekuritas Maximilianus Nico Demus said: "This expansion is also considered to be able to open Kimia Farma's access to experts from global investors.” He added that Kimia Farma's capital structure and liquidity will strengthen. “More than that, the company also can open the door to the international market for Kimia Farma's business and network, from the retail and health services."
Read the latest news and announcements from INA